Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07334236

Energy Ramping Versus Fixed Dose ESWL

Energy Ramping Versus Fixed Dose ESWL on Stone-Free Rate (Comparative Study)

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
mohammed Abdelhafez · Academic / Other
Sex
All
Age
80 Years
Healthy volunteers
Accepted

Summary

This clinical trial compares two techniques of extracorporeal shock wave lithotripsy (ESWL) - energy ramping versus fixed dose - in adult patients with renal stones. The study aims to evaluate stone-free rates, retreatment needs, and safety outcomes across multiple clinical sites in Egypt.

Detailed description

This multi-center, randomized controlled trial investigates the impact of energy ramping versus fixed-dose ESWL on stone clearance in patients with solitary renal calculi. Participants will be assigned to either a gradually increasing energy protocol or a constant energy protocol using standardized lithotripter settings. The primary outcome is stone-free rate at two weeks post-treatment, assessed via imaging. Secondary outcomes include retreatment rate, pain scores, adverse events, and procedure duration. The study is conducted under IRB approval from Sohag University and follows international ethical standards for human research.

Conditions

Interventions

TypeNameDescription
PROCEDUREExtracorporeal shock wave lithotripsyFixed Voltage (experimental): Subjects receive shock wave therapy at a constant energy level (e.g., 20-22 kV) for the entire duration of the session. Standard delivery includes approximately 3,000 shocks at a frequency of 60-90 shocks per minute. Voltage Ramping (control): Subjects receive shock wave therapy starting at a low energy level (e.g., 6-10 kV) for an initial "priming" phase of 100-500 shocks. Energy is then escalated in predefined increments (e.g., 1-2 kV every 250-500 shocks) until reaching the target therapeutic voltage.

Timeline

Start date
2026-01-03
Primary completion
2026-06-01
Completion
2026-11-01
First posted
2026-01-12
Last updated
2026-01-12

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07334236. Inclusion in this directory is not an endorsement.